SCHEMBL30483971

SCHEMBL30483971

CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 13/20 0.55
▸ NPY1R P25929 8/20 0.55
▸ NPY5R Q15761 7/20 0.55
▸ NPY2R P49146 4/20 0.55
▸ OPRD1 P41143 1/20 0.54
▸ VIPR1 P32241 1/20 0.50
▸ VIPR2 P41587 1/20 0.50
▸ KISS1R Q969F8 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30558177 0.90 NPY4R (0.63) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL30483973 0.88 VIPR2 (0.55) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL30198871 0.88 NPY4R (0.59) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL29539204 0.88 NPY4R (0.55) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL11886062 0.88 NPY4R (0.55) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL29857796 0.88 NPY4R (0.55) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL29617176 0.88 NPY4R (0.55) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL29602482 0.88 NPY4R (0.59) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL9755304 0.87 NPY4R (0.72) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL11886065 0.87 NPY4R (0.56) NPY4RNPY1RNPY5RNPY2RKISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126533-A1 Method of treating an inflammatory disorder UNIVERSITY OF MIAMI 2023-04-27 — — US claimed
US-20240287153-A1 Treating Inflammatory Lung Disease THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2024-08-29 — — US disclosed
US-11993640-B2 Treating inflammatory lung disease THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2024-05-28 — — US disclosed
US-20230126533-A1 Method of treating an inflammatory disorder UNIVERSITY OF MIAMI 2023-04-27 — — US disclosed
Send feedback